BIOCARE Lifesciences Inc. (BLI), a Philippine-based pharmaceutical company announced the launch of the first branded generic of tocilizumab (Temziva) 400mg/20ml solution for infusion.

Temziva is approved as a Drug Product for Emergency Use Only (DEU). SRS Life Sciences holds the registration for tocilizumab in the Philippines, while AryoGen will produce the therapy and Biocare Lifesciences will distribute the therapy to hospitals in the Philippines.